Asia Pacific Corneal Transplant Market

Asia Pacific Corneal Transplant Market

The Asia-Pacific corneal transplant market is expected to reach USD 123.59 million by 2031 from USD 71.26 million in 2023, growing at a CAGR of 7.2% in the forecast period of 2024 to 2031.

Asia-Pacific Corneal Transplant Market, By Procedure Type (Endothelial Keratoplasty, Penetrating Keratoplasty, Anterior Lamellar Keratoplasty (ALK), Corneal Limbal Stem Cell Transplant, Artifical Cornea Transplant, and Others), Type (Human Cornea and Synthetic), Donor Type (Autograft and Allograft), Graft Type (Partial Thickness Grafts (Lamellar) and Full Thickness Grafts (Penetrating)), Surgery Type (Conventional Surgery, Laser-Assisted Surgery), Indication (Fuch's Endothelial Dystrophy, Infectious Keratitis, Bullous Keratopathy, Keratoconus, Regraft Procedures, Corneal Scarring, Corneal Ulcers, and Others), Gender (Female and Male), Age Group (Geriatric, Adult, and Pediatric), End User (Hospitals, Eye Clinics, Ambulatory Surgical Centers, Academic & Research Institutes, and Others), Countries (China, India, Japan, Australia, South Korea, Singapore, Philippines, Malaysia, Indonesia, Thailand and Rest of Asia-Pacific) - Industry Trends and Forecast to 2031

Overview of Asia-Pacific Corneal Transplant Market Dynamics:

Driver

• Increasing prevalence of eye diseases
Restrain

• High cost associated with corneal transplant surgery

Opportunity

• Rise in healthcare infrastructure

Market Players:

The key market players operating in the Asia-Pacific corneal transplant market are listed below:

• ZEISS Group (Carl Zeiss Meditec AG.)
• Alcon
• Ziemer Ophthalmic Systems AG
• RUMEX International Co.
• AJL Ophthalmic S.A.